Palo Protocol: Nasal
Pinealon 20 mg Nasal
Cognitive
20 mg in 10 ml · 15 ml bottle
Twenty times the strength of the oral capsule, delivered by a route that skips first-pass metabolism entirely. The evidence base did not grow with the dose — it is the same small body of work from the same research tradition. We are listing it because you will find it elsewhere anyway, and you should find it here with the caveat attached.
Not available for purchase
What we know
- Mechanism
- The tripeptide bioregulator from the Epithalon research programme, at 20 mg via intranasal delivery.
- Evidence state
- Limited published literature from a single research tradition.
- Regulatory note
- Not approved in the US. Supplier marks the nasal range 'For Research Use Only'.
Disclaimer
This product is not available for purchase. It has not been evaluated by the FDA and is not intended to diagnose, treat, cure or prevent any disease. Nothing on this page is medical advice. Palo lists this compound for transparency about our supply partnerships; any future availability would run through a licensed prescriber and a compounding pharmacy, not through this website.